Prediction of deleterious functional effects of non-synonymous single nucleotide polymorphisms in human nuclear receptor genes using a bioinformatics approach

Drug Metabolism Letters

Volumn 3, Issue 4, 2009, Pages 242-286

  Liu, Ya He ^a   Li, Chun Guang ^a   Zhou, Shu Feng ^a  

^a RMIT UNIVERSITY   (Australia)

Author keywords

Androgen receptor; Non synonymous single nucleotide polymorphism; Nuclear receptor; Phenotype; Prediction

Indexed keywords

ANDROGEN RECEPTOR; CELL NUCLEUS RECEPTOR; DRUG METABOLIZING ENZYME; HORMONE RECEPTOR;

AMINO ACID SUBSTITUTION; ARTICLE; BIOINFORMATICS; DISEASE PREDISPOSITION; GENE FUNCTION; GENE MUTATION; HUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ALGORITHMS; AMINO ACID SUBSTITUTION; COMPUTATIONAL BIOLOGY; HUMANS; MUTATION; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CYTOPLASMIC AND NUCLEAR;

EID: 74749095050     PISSN: 18723128     EISSN: None     Source Type: Journal    
DOI: 10.2174/187231209790218145     Document Type: Article

References (203)

1. Mangelsdorf, D. J.; Thummel, C.; Beato, M.; Herrlich, P.; Schutz, G.; Umesono, K.; Blumberg, B.; Kastner, P.; Mark, M.; Chambon, P.; Evans, R. M. The nuclear receptor superfamily: the second decade. Cell, 1995, 83(6), 835-839.
2. Germain, P.; Staels, B.; Dacquet, C.; Spedding, M.; Laudet, V. Overview of nomenclature of nuclear receptors. Pharmacol. Rev., 2006, 58(4), 685-704.
3. Cargill, M.; Altshuler, D.; Ireland, J.; Sklar, P.; Ardlie, K.; Patil, N.; Shaw, N.; Lane, C. R.; Lim, E. P.; Kalyanaraman, N.; Nemesh, J.; Ziaugra, L.; Friedland, L.; Rolfe, A.; Warrington, J.; Lipshutz, R.; Daley, G. Q.; Lander, E. S. Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nat. Genet., 1999, 22(3), 231-238..
4. Nadeau, J. H. Single nucleotide polymorphisms: tackling complexity. Nature, 2002, 420(6915), 517-518.
5. Sunyaev, S.; Ramensky, V.; Bork, P. Towards a structural basis of human non-synonymous single nucleotide polymorphisms. Trends Genet., 2000, 16(5), 198-200.
6. Zhernakova, A.; van Diemen, C. C.; Wijmenga, C. Detecting shared pathogenesis from the shared genetics of immune-related diseases. Nat. Rev. Genet., 2009, 10(1), 43-55.
7. Ng, P. C.; Henikoff, S. SIFT: Predicting amino acid changes that affect protein function. Nucleic Acids Res., 2003, 31(13), 3812-3814.
8. Ramensky, V.; Bork, P.; Sunyaev, S. Human non-synonymous SNPs: server and survey. Nucleic Acids Res., 2002, 30(17), 3894-3900.
9. Yue, P.; Melamud, E.; Moult, J. SNPs3D: candidate gene and SNP selection for association studies. BMC Bioinformatics, 2006, 7, 166.
10. Ferrer-Costa, C.; Gelpi, J. L.; Zamakola, L.; Parraga, I.; de la Cruz, X.; Orozco, M. PMUT: a web-based tool for the annotation of pathological mutations on proteins. Bioinformatics, 2005, 21(14), 3176-3178.
11. Stitziel, N. O.; Binkowski, T. A.; Tseng, Y. Y.; Kasif, S.; Liang, J. topoSNP: a topographic database of non-synonymous single nucleotide polymorphisms with and without known disease association. Nucleic Acids Res., 2004, 32(Database issue), D520-522.
12. Nuclear Receptors Committee A unified nomenclature system for the nuclear receptor superfamily. Cell, 1999, 97(2), 161-163.
13. Horn, F.; Vriend, G.; Cohen, F. E. Collecting and harvesting biological data: the GPCRDB and NucleaRDB information systems. Nucleic Acids Res., 2001, 29(1), 346-349.
14. Teng, S.; Michonova-Alexova, E.; Alexov, E. Approaches and resources for prediction of the effects of non-synonymous single nucleotide polymorphism on protein function and interactions. Curr. Pharm. Biotechnol., 2008, 9(2), 123-133.
15. Altschul, S. F.; Madden, T. L.; Schaffer, A. A.; Zhang, J.; Zhang, Z.; Miller, W.; Lipman, D. J. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res., 1997, 25(17), 3389-3402.
16. Ng, P. C.; Henikoff, S. Predicting deleterious amino acid substitutions. Genome Res., 2001, 11(5), 863-874.
17. Xi, T.; Jones, I. M.; Mohrenweiser, H. W. Many amino acid substitution variants identified in DNA repair genes during human population screenings are predicted to impact protein function. Genomics, 2004, 83(6), 970-979.
18. Plackett, R. L. Karl Pearson and the Chi-Squared Test. Int. Stat. Rev., 1983, 51(1), 59-72.
19. Shi, X. B.; Ma, A. H.; Xia, L.; Kung, H. J.; de Vere White, R. W. Functional analysis of 44 mutant androgen receptors from human prostate cancer. Cancer Res., 2002, 62(5), 1496-1502.
20. Zoppi, S.; Marcelli, M.; Deslypere, J. P.; Griffin, J. E.; Wilson, J. D.; McPhaul, M. J. Amino acid substitutions in the DNA-binding domain of the human androgen receptor are a frequent cause of receptor-binding positive androgen resistance. Mol. Endocrinol., 1992, 6(3), 409-415.
21. Tora, L.; Mullick, A.; Metzger, D.; Ponglikitmongkol, M.; Park, I.; Chambon, P. The cloned human oestrogen receptor contains a mutation which alters its hormone binding properties. Embo. J., 1989, 8(7), 1981-1986.
22. Murono, K.; Mendonca, B. B.; Arnhold, I. J.; Rigon, A. C.; Migeon, C. J.; Brown, T. R. Human androgen insensitivity due to point mutations encoding amino acid substitutions in the androgen receptor steroid-binding domain. Hum. Mutat., 1995, 6(2), 152-162.
23. Ruiz, M.; Lind, U.; Gafvels, M.; Eggertsen, G.; Carlstedt-Duke, J.; Nilsson, L.; Holtmann, M.; Stierna, P.; Wikstrom, A. C.; Werner, S. Characterization of two novel mutations in the glucocorticoid receptor gene in patients with primary cortisol resistance. Clin. Endocrinol. (Oxf), 2001, 55(3), 363-371.
24. Hani, E. H.; Suaud, L.; Boutin, P.; Chevre, J. C.; Durand, E.; Philippi, A.; Demenais, F.; Vionnet, N.; Furuta, H.; Velho, G.; Bell, G. I.; Laine, B.; Froguel, P. A missense mutation in hepatocyte nuclear factor-4α, resulting in a reduced transactivation activity, in human late-onset non-insulin- dependent diabetes mellitus. J. Clin. Invest., 1998, 101(3), 521-526.
25. Sarraf, P.; Mueller, E.; Smith, W. M.; Wright, H. M.; Kum, J. B.; Aaltonen, L. A.; de la Chapelle, A.; Spiegelman, B. M.; Eng, C. Loss-of-function mutations in PPAR-γ associated with human colon cancer. Mol. Cell, 1999, 3(6), 799-804.
26. Quigley, C. A.; De Bellis, A.; Marschke, K. B.; el-Awady, M. K.; Wilson, E. M.; French, F. S. Androgen receptor defects: historical, clinical, and molecular perspectives. Endocr. Rev., 1995, 16(3), 271-321.
27. Ingles, S. A.; Ross, R. K.; Yu, M. C.; Irvine, R. A.; La Pera, G.; Haile, R. W.; Coetzee, G. A. Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor. J. Natl. Cancer Inst., 1997, 89(2), 166-170.
28. Slattery, M. L. Vitamin D receptor gene (VDR) associations with cancer. Nutr. Rev., 2007, 65(8 Pt 2), S102-104.
29. Zmuda, J. M.; Cauley, J. A.; Ferrell, R. E. Molecular epidemiology of vitamin D receptor gene variants. Epidemiol. Rev., 2000, 22(2), 203-217.
30. Kliewer, S. A.; Willson, T. M. Regulation of xenobiotic and bile acid metabolism by the nuclear pregnane X receptor. J. Lipid Res., 2002, 43(3), 359-364.
31. Kliewer, S. A. The nuclear pregnane X receptor regulates xenobiotic detoxification. J. Nutr., 2003, 133(Suppl.7), 2444S-2447S.
32. Bernal, J. Pathophysiology of thyroid hormone deficiency during fetal development. J. Pediatr. Endocrinol. Metab., 2005, 18(Suppl 1), 1253-1256.
33. Williams, G. R.; Robson, H.; Shalet, S. M. Thyroid hormone actions on cartilage and bone: interactions with other hormones at the epiphyseal plate and effects on linear growth. J. Endocrinol., 1998, 157(3), 391-403.
34. Xu, C. F.; Lewis, K.; Cantone, K. L.; Khan, P.; Donnelly, C.; White, N.; Crocker, N.; Boyd, P. R.; Zaykin, D. V.; Purvis, I. J. Effectiveness of computational methods in haplotype prediction. Hum. Genet., 2002, 110(2), 148-156.
35. Wang, Z.; Moult, J. SNPs, protein structure, and disease. Hum. Mutat., 2001, 17(4), 263-270.
36. Henikoff, S.; Henikoff, J. G. Amino acid substitution matrices from protein blocks. Proc. Natl. Acad. Sci. USA, 1992, 89(22), 10915-10919.
37. Godzik, A.; Jambon, M.; Friedberg, I. Computational protein function prediction: are we making progress? Cell Mol. Life Sci., 2007, 64(19-20), 2505-2511.
38. Stitziel, N. O.; Tseng, Y. Y.; Pervouchine, D.; Goddeau, D.; Kasif, S.; Liang, J. Structural location of disease-associated single-nucleotide polymorphisms. J. Mol. Biol., 2003, 327(5), 1021-1030.
39. Sunyaev, S.; Ramensky, V.; Koch, I.; Lathe, W., 3rd; Kondrashov, A. S.; Bork, P. Prediction of deleterious human alleles. Hum. Mol. Genet., 2001, 10(6), 591-597.
40. Liu, J.; Lewohl, J. M.; Harris, R. A.; Dodd, P. R.; Mayfield, R. D. Altered gene expression profiles in the frontal cortex of cirrhotic alcoholics. Alcohol. Clin. Exp. Res., 2007, 31(9), 1460-1466.
41. Wang, L. L.; Li, Y.; Zhou, S. F. A bioinformatics approach for the phenotype prediction of non-synonymous single nucleotide polymorphisms in human cytochrome P450s. Drug Metab. Dispos., 2009, 37(5), 977-991.
42. Ng, P. C.; Henikoff, S. Accounting for human polymorphisms predicted to affect protein function. Genome. Res., 2002, 12(3), 436-446.
43. Chasman, D.; Adams, R. M. Predicting the functional consequences of non-synonymous single nucleotide polymorphisms: structure-based assessment of amino acid variation. J. Mol. Biol., 2001, 307(2), 683-706.
44. Domanski, T. L.; Halpert, J. R. Analysis of mammalian cytochrome P450 structure and function by site-directed mutagenesis. Curr. Drug Metab., 2001, 2(2), 117-137.
45. Ng, P. C.; Henikoff, S. Predicting the effects of amino acid substitutions on protein function. Annu. Rev. Genomics. Hum. Genet., 2006, 7, 61-80.
46. Choong, C. S.; Quigley, C. A.; French, F. S.; Wilson, E. M. A novel missense mutation in the amino-terminal domain of the human androgen receptor gene in a family with partial androgen insensitivity syndrome causes reduced efficiency of protein translation. J. Clin. Invest., 1996, 98(6), 1423-1431.
47. Tilley, W. D.; Buchanan, G.; Hickey, T. E.; Bentel, J. M. Mutations in the androgen receptor gene are associated with progression of human prostate cancer to androgen independence. Clin. Cancer Res., 1996, 2(2), 277-285.
48. Yeh, S. H.; Chiu, C. M.; Chen, C. L.; Lu, S. F.; Hsu, H. C.; Chen, D. S.; Chen, P. J. Somatic mutations at the trinucleotide repeats of androgen receptor gene in male hepatocellular carcinoma. Int. J. Cancer, 2007, 120(8), 1610-1617.
49. Komori, S.; Sakata, K.; Tanaka, H.; Shima, H.; Koyama, K. DNA analysis of the androgen receptor gene in two cases with complete androgen insensitivity syndrome. J. Obstet. Gynaecol. Res., 1997, 23(3), 277-281.
50. Macke, J. P.; Hu, N.; Hu, S.; Bailey, M.; King, V. L.; Brown, T.; Hamer, D.; Nathans, J. Sequence variation in the androgen receptor gene is not a common determinant of male sexual orientation. Am. J. Hum. Genet., 1993, 53(4), 844-852.
51. Wang, Q.; Ghadessy, F. J.; Yong, E. L. Analysis of the transactivation domain of the androgen receptor in patients with male infertility. Clin. Genet., 1998, 54(3), 185-192.
52. Tanaka, H.; Komori, S.; Sakata, K.; Shima, H.; Koyama, K. One additional mutation at exon A amplifies thermolability of androgen receptor in a case with complete androgen insensitivity syndrome. Gynecol. Endocrinol., 1998, 12(2), 75-82.
53. Castagnaro, M.; Yandell, D. W.; Dockhorn-Dworniczak, B.; Wolfe, H. J.; Poremba, C. [Androgen receptor gene mutations and p53 gene analysis in advanced prostate cancer]. Verh. Dtsch. Ges. Pathol., 1993, 77, 119-123.
54. Gottlieb, B.; Vasiliou, D. M.; Lumbroso, R.; Beitel, L. K.; Pinsky, L.; Trifiro, M. A. Analysis of exon 1 mutations in the androgen receptor gene. Hum. Mutat., 1999, 14(6), 527-539.
55. Hiort, O.; Holterhus, P. M.; Horter, T.; Schulze, W.; Kremke, B.; Bals-Pratsch, M.; Sinnecker, G. H.; Kruse, K. Significance of mutations in the androgen receptor gene in males with idiopathic infertility. J. Clin. Endocrinol. Metab., 2000, 85(8), 2810-2815.
56. Ahmed, S. F.; Cheng, A.; Dovey, L.; Hawkins, J. R.; Martin, H.; Rowland, J.; Shimura, N.; Tait, A. D.; Hughes, I. A. Phenotypic features, androgen receptor binding, and mutational analysis in 278 clinical cases reported as androgen insensitivity syndrome. J. Clin. Endocrinol. Metab., 2000, 85(2), 658-665.
57. Bouvattier, C.; Carel, J. C.; Lecointre, C.; David, A.; Sultan, C.; Bertrand, A. M.; Morel, Y.; Chaussain, J. L. Postnatal changes of T, LH, and FSH in 46,XY infants with mutations in the AR gene. J. Clin. Endocrinol. Metab., 2002, 87(1), 29-32.
58. Zuccarello, D.; Ferlin, A.; Vinanzi, C.; Prana, E.; Garolla, A.; Callewaert, L.; Claessens, F.; Brinkmann, A. O.; Foresta, C. Detailed functional studies on androgen receptor mild mutations demonstrate their association with male infertility. Clin. Endocrinol. (Oxf), 2008, 68(4), 580-588.
59. Sutherland, R. W.; Wiener, J. S.; Hicks, J. P.; Marcelli, M.; Gonzales, E. T., Jr.; Roth, D. R.; Lamb, D. J. Androgen receptor gene mutations are rarely associated with isolated penile hypospadias. J. Urol., 1996, 156(2 Pt 2), 828-831.
60. Allera, A.; Herbst, M. A.; Griffin, J. E.; Wilson, J. D.; Schweikert, H. U.; McPhaul, M. J. Mutations of the androgen receptor coding sequence are infrequent in patients with isolated hypospadias. J. Clin. Endocrinol. Metab., 1995, 80(9), 2697-2699.
61. Poukka, H.; Aarnisalo, P.; Santti, H.; Janne, O. A.; Palvimo, J. J. Coregulator small nuclear RING finger protein (SNURF) enhances Sp1- and steroid receptor-mediated transcription by different mechanisms. J. Biol. Chem., 2000, 275(1), 571-579.
62. Lobaccaro, J. M.; Belon, C.; Lumbroso, S.; Olewniczack, G.; Carre-Pigeon, F.; Job, J. C.; Chaussain, J. L.; Toublanc, J. E.; Sultan, C. Molecular prenatal diagnosis of partial androgen insensitiv ity syndrome based on the Hind III polymorphism of the androgen receptor gene. Clin. Endocrinol. (Oxf), 1994, 40(3), 297-302.
63. Komori, S.; Kasumi, H.; Sakata, K.; Tanaka, H.; Hamada, K.; Koyama, K. Molecular analysis of the androgen receptor gene in 4 patients with complete androgen insensitivity. Arch. Gynecol. Obstet., 1998, 261(2), 95-100.
64. Bruggenwirth, H. T.; Boehmer, A. L.; Verleun-Mooijman, M. C.; Hoogenboezem, T.; Kleijer, W. J.; Otten, B. J.; Trapman, J.; Brinkmann, A. O. Molecular basis of androgen insensitivity. J. Steroid Biochem. Mol. Biol., 1996, 58(5-6), 569-575.
65. Marcelli, M.; Ittmann, M.; Mariani, S.; Sutherland, R.; Nigam, R.; Murthy, L.; Zhao, Y.; DiConcini, D.; Puxeddu, E.; Esen, A.; Eastham, J.; Weigel, N. L.; Lamb, D. J. Androgen receptor mutations in prostate cancer. Cancer Res., 2000, 60(4), 944-949.
66. Hooper, H. T.; Figueiredo, B. C.; Pavan-Senn, C. C.; De Lacerda, L.; Sandrini, R.; Mengarelli, J. K.; Japp, K.; Karaviti, L. P. Concordance of phenotypic expression and gender identity in a large kindred with a mutation in the androgen receptor. Clin. Genet., 2004, 65(3), 183-190.
67. Imasaki, K.; Okabe, T.; Murakami, H.; Tanaka, Y.; Haji, M.; Takayanagi, R.; Nawata, H. Androgen insensitivity syndrome due to new mutations in the DNA-binding domain of the androgen receptor. Mol. Cell Endocrinol., 1996, 120(1), 15-24.
68. Sultan, C.; Lumbroso, S.; Poujol, N.; Belon, C.; Boudon, C.; Lobaccaro, J. M. Mutations of androgen receptor gene in androgen insensitivity syndromes. J. Steroid Biochem. Mol. Biol., 1993, 46(5), 519-530.
69. Lumbroso, S.; Lobaccaro, J. M.; Belon, C.; Martin, D.; Chaussain, J. L.; Sultan, C. A new mutation within the deoxyribonucleic acid-binding domain of the androgen receptor gene in a family with complete androgen insensitivity syndrome. Fertil. Steril., 1993, 60(5), 814-819.
70. Hiort, O.; Klauber, G.; Cendron, M.; Sinnecker, G. H.; Keim, L.; Schwinger, E.; Wolfe, H. J.; Yandell, D. W. Molecular characterization of the androgen receptor gene in boys with hypospadias. Eur. J. Pediatr., 1994, 153(5), 317-321.
71. Black, B. E.; Vitto, M. J.; Gioeli, D.; Spencer, A.; Afshar, N.; Conaway, M. R.; Weber, M. J.; Paschal, B. M. Transient, ligand-dependent arrest of the androgen receptor in subnuclear foci alters phosphorylation and coactivator interactions. Mol. Endocrinol., 2004, 18(4), 834-850.
72. Holterhus, P. M.; Wiebel, J.; Sinnecker, G. H.; Bruggenwirth, H. T.; Sippell, W. G.; Brinkmann, A. O.; Kruse, K.; Hiort, O. Clinical and molecular spectrum of somatic mosaicism in androgen insensitivity syndrome. Pediatr. Res., 1999, 46(6), 684-690.
73. Gast, A.; Neuschmid-Kaspar, F.; Klocker, H.; Cato, A. C. A single amino acid exchange abolishes dimerization of the androgen receptor and causes Reifenstein syndrome. Mol. Cell Endocrinol., 1995, 111(1), 93-98.
74. Nordenskjold, A.; Friedman, E.; Tapper-Persson, M.; Soderhall, C.; Leviav, A.; Svensson, J.; Anvret, M. Screening for mutations in candidate genes for hypospadias. Urol. Res., 1999, 27(1), 49-55.
75. Baldazzi, L.; Baroncini, C.; Pirazzoli, P.; Balsamo, A.; Capelli, M.; Marchetti, G.; Bernardi, F.; Cacciari, E. Two mutations causing complete androgen insensitivity: a frame-shift in the steroid binding domain and a Cys → Phe substitution in the second zinc finger of the androgen receptor. Hum. Mol. Genet., 1994, 3(7), 1169-1170.
76. Weidemann, W.; Linck, B.; Haupt, H.; Mentrup, B.; Romalo, G.; Stockklauser, K.; Brinkmann, A. O.; Schweikert, H. U.; Spindler, K. D. Clinical and biochemical investigations and molecular analysis of subjects with mutations in the androgen receptor gene. Clin. Endocrinol. (Oxf), 1996, 45(6), 733-739.
77. Lobaccaro, J. M.; Lumbroso, S.; Berta, P.; Chaussain, J. L.; Sultan, C. Complete androgen insensitivity syndrome associated with a de novo mutation of the androgen receptor gene detected by single strand conformation polymorphism. J. Steroid Biochem. Mol. Biol., 1993, 44(3), 211-216.
78. Gottlieb, B.; Beitel, L. K.; Wu, J. H.; Trifiro, M. The androgen receptor gene mutations database (ARDB): 2004 update. Hum. Mutat., 2004, 23(6), 527-533.
79. Ris-Stalpers, C.; Hoogenboezem, T.; Sleddens, H. F.; Verleun-Mooijman, M. C.; Degenhart, H. J.; Drop, S. L.; Halley, D. J.; Oosterwijk, J. C.; Hodgins, M. B.; Trapman, J.; et al. A practical approach to the detection of androgen receptor gene mutations and pedigree analysis in families with X-linked androgen insensitivity. Pediatr. Res., 1994, 36(2), 227-234.
80. Hiort, O.; Sinnecker, G. H.; Holterhus, P. M.; Nitsche, E. M.; Kruse, K. The clinical and molecular spectrum of androgen insensitivity syndromes. Am. J. Med. Genet., 1996, 63(1), 218-222.
81. Lobaccaro, J. M.; Poujol, N.; Chiche, L.; Lumbroso, S.; Brown, T. R.; Sultan, C. Molecular modeling and in vitro investigations of the human androgen receptor DNA-binding domain: application for the study of two mutations. Mol. Cell Endocrinol., 1996, 116(2), 137-147.
82. De Bellis, A.; Quigley, C. A.; Cariello, N. F.; el-Awady, M. K.; Sar, M.; Lane, M. V.; Wilson, E. M.; French, F. S. Single base mutations in the human androgen receptor gene causing complete androgen insensitivity: rapid detection by a modified denaturing gradient gel electrophoresis technique. Mol. Endocrinol., 1992, 6(11), 1909-1920.
83. Wang, C.; Uchida, T. [Androgen receptor gene mutations in prostate cancer]. Nippon Hinyokika Gakkai Zasshi, 1997, 88(5), 550-556.
84. Werner, R.; Holterhus, P. M.; Binder, G.; Schwarz, H. P.; Morlot, M.; Struve, D.; Marschke, C.; Hiort, O. The A645D mutation in the hinge region of the human androgen receptor (AR) gene modulates AR activity, depending on the context of the polymorphic glutamine and glycine repeats. J. Clin. Endocrinol. Metab., 2006, 91(9), 3515-3520.
85. Taplin, M. E.; Bubley, G. J.; Shuster, T. D.; Frantz, M. E.; Spooner, A. E.; Ogata, G. K.; Keer, H. N.; Balk, S. P. Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer. N. Engl. J. Med., 1995, 332(21), 1393-1398.
86. Giwercman, Y. L.; Nordenskjold, A.; Ritzen, E. M.; Nilsson, K. O.; Ivarsson, S. A.; Grandell, U.; Wedell, A. An androgen receptor gene mutation (E653K) in a family with congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency as well as in partial androgen insensitivity. J. Clin. Endocrinol. Metab., 2002, 87(6), 2623-2628.
87. Pinsky, L.; Trifiro, M.; Kaufman, M.; Beitel, L. K.; Mhatre, A.; Kazemi-Esfarjani, P.; Sabbaghian, N.; Lumbroso, R.; Alvarado, C.; Vasiliou, M.; et al. Androgen resistance due to mutation of the androgen receptor. Clin. Invest. Med., 1992, 15(5), 456-472.
88. Belsham, D. D.; Pereira, F.; Greenberg, C. R.; Liao, S.; Wrogemann, K. Leu-676-Pro mutation of the androgen receptor causes complete androgen insensitivity syndrome in a large Hutterite kindred. Hum. Mutat., 1995, 5(1), 28-33.
89. Chen, C. P.; Chern, S. R.; Wang, T. Y.; Wang, W.; Wang, K. L.; Jeng, C. J. Androgen receptor gene mutations in 46,XY females with germ cell tumours. Hum. Reprod., 1999, 14(3), 664-670.
90. Chavez, B.; Mendez, J. P.; Ulloa-Aguirre, A.; Larrea, F.; Vilchis, F. Eight novel mutations of the androgen receptor gene in patients with androgen insensitivity syndrome. J. Hum. Genet., 2001, 46(10), 560-565.
91. Hiort, O.; Sinnecker, G. H.; Holterhus, P. M.; Nitsche, E. M.; Kruse, K. Inherited and de novo androgen receptor gene mutations: investigation of single-case families. J. Pediatr., 1998, 132(6), 939-943.
92. Ris-Stalpers, C.; Trifiro, M. A.; Kuiper, G. G.; Jenster, G.; Romalo, G.; Sai, T.; van Rooij, H. C.; Kaufman, M.; Rosenfield, R. L.; Liao, S.; et al. Substitution of aspartic acid-686 by histidine or asparagine in the human androgen receptor leads to a functionally inactive protein with altered hormone-binding characteristics. Mol. Endocrinol., 1991, 5(10), 1562-1569.
93. Dork, T.; Schnieders, F.; Jakubiczka, S.; Wieacker, P.; Schroeder-Kurth, T.; Schmidtke, J. A new missense substitution at a mutational hot spot of the androgen receptor in siblings with complete androgen insensitivity syndrome. Hum. Mutat., 1998, 11(4), 337-339.
94. Hannema, S. E.; Scott, I. S.; Hodapp, J.; Martin, H.; Coleman, N.; Schwabe, J. W.; Hughes, I. A. Residual activity of mutant androgen receptors explains wolffian duct development in the complete androgen insensitivity syndrome. J. Clin. Endocrinol. Metab., 2004, 89(11), 5815-5822.
95. Radmayr, C.; Culig, Z.; Glatzl, J.; Neuschmid-Kaspar, F.; Bartsch, G.; Klocker, H. Androgen receptor point mutations as the underlying molecular defect in 2 patients with androgen insensitivity syndrome. J. Urol., 1997, 158(4), 1553-1556.
96. Sills, E. S.; Sholes, T. E.; Perloe, M.; Kaplan, C. R.; Davis, J. G.; Tucker, M. J. Characterization of a novel receptor mutation A→T at exon 4 in complete androgen insensitivity syndrome and a carrier sibling via bidirectional polymorphism sequence analysis. Int. J. Mol. Med., 2002, 9(1), 45-48.
97. Lumbroso, S.; Lobaccaro, J. M.; Georget, V.; Leger, J.; Poujol, N.; Terouanne, B.; Evain-Brion, D.; Czernichow, P.; Sultan, C. A novel substitution (Leu707Arg) in exon 4 of the androgen receptor gene causes complete androgen resistance. J. Clin. Endocrinol. Metab., 1996, 81(5), 1984-1988.
98. Albers, N.; Ulrichs, C.; Gluer, S.; Hiort, O.; Sinnecker, G. H.; Mildenberger, H.; Brodehl, J. Etiologic classification of severe hypospadias: implications for prognosis and management. J. Pediatr., 1997, 131(3), 386-392.
99. Culig, Z.; Hobisch, A.; Cronauer, M. V.; Cato, A. C.; Hittmair, A.; Radmayr, C.; Eberle, J.; Bartsch, G.; Klocker, H. Mutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgens and progesterone. Mol. Endocrinol., 1993, 7(12), 1541-1550.
100. Ghali, S. A.; Gottlieb, B.; Lumbroso, R.; Beitel, L. K.; Elhaji, Y.; Wu, J.; Pinsky, L.; Trifiro, M. A. The use of androgen receptor amino/carboxyl- terminal interaction assays to investigate androgen receptor gene mutations in subjects with varying degrees of androgen insensitivity. J. Clin. Endocrinol. Metab., 2003, 88(5), 2185-2193.
101. Elo, J. P.; Kvist, L.; Leinonen, K.; Isomaa, V.; Henttu, P.; Lukkarinen, O.; Vihko, P. Mutated human androgen receptor gene detected in a prostatic cancer patient is also activated by estradiol. J. Clin. Endocrinol. Metab., 1995, 80(12), 3494-3500.
102. Yong, E. L.; Ng, S. C.; Roy, A. C.; Yun, G.; Ratnam, S. S. Pregnancy after hormonal correction of severe spermatogenic defect due to mutation in androgen receptor gene. Lancet, 1994, 344(8925), 826-827.
103. McPhaul, M. J.; Marcelli, M.; Zoppi, S.; Wilson, C. M.; Griffin, J. E.; Wilson, J. D. Mutations in the ligand-binding domain of the androgen receptor gene cluster in two regions of the gene. J. Clin. Invest., 1992, 90(5), 2097-2101.
104. Ko, T. M.; Yang, Y. S.; Wu, M. Y.; Kao, C. H.; Hsu, P. M.; Chuang, S. M.; Lee, T. Y. Complete androgen insensitivity syndrome. Molecular characterization in two Chinese women. J. Reprod. Med., 1997, 42(7), 424-428.
105. Wilson, C. M.; Griffin, J. E.; Wilson, J. D.; Marcelli, M.; Zoppi, S.; McPhaul, M. J. Immunoreactive androgen receptor expression in subjects with androgen resistance. J. Clin. Endocrinol. Metab., 1992, 75(6), 1474-1478.
106. Bevan, C. L.; Brown, B. B.; Davies, H. R.; Evans, B. A.; Hughes, I. A.; Patterson, M. N. Functional analysis of six androgen receptor mutations identified in patients with partial androgen insensitivity syndrome. Hum. Mol. Genet., 1996, 5(2), 265-273.
107. Nakao, R.; Yanase, T.; Sakai, Y.; Haji, M.; Nawata, H. A single amino acid substitution (Gly743 → Val) in the steroid-binding domain of the human androgen receptor leads to Reifenstein syndrome. J. Clin. Endocrinol. Metab., 1993, 77(1), 103-107.
108. Boehmer, A. L.; Brinkmann, O.; Bruggenwirth, H.; van Assendelft, C.; Otten, B. J.; Verleun-Mooijman, M. C.; Niermeijer, M. F.; Brunner, H. G.; Rouwe, C. W.; Waelkens, J. J.; Oostdijk, W.; Kleijer, W. J.; van der Kwast, T. H.; de Vroede, M. A.; Drop, S. L. Genotype versus phenotype in families with androgen insensitivity syndrome. J. Clin. Endocrinol. Metab., 2001, 86(9), 4151-4160.
109. Marcelli, M.; Zoppi, S.; Wilson, C. M.; Griffin, J. E.; McPhaul, M. J. Amino acid substitutions in the hormone-binding domain of the human androgen receptor alter the stability of the hormone receptor complex. J. Clin. Invest., 1994, 94(4), 1642-1650.
110. Bevan, C. L.; Hughes, I. A.; Patterson, M. N. Wide variation in androgen receptor dysfunction in complete androgen insensitivity syndrome. J. Steroid Biochem. Mol. Biol., 1997, 61(1-2), 19-26.
111. Takahashi, H.; Furusato, M.; Allsbrook, W. C., Jr.; Nishii, H.; Wakui, S.; Barrett, J. C.; Boyd, J. Prevalence of androgen receptor gene mutations in latent prostatic carcinomas from Japanese men. Cancer Res., 1995, 55(8), 1621-1624.
112. 2-/carboxyl-terminal interactions in androgen receptor dimerization revealed by mutations that cause androgen insensitivity. J. Biol. Chem., 1998, 273(1), 92-101.
113. Lobaccaro, J. M.; Lumbroso, S.; Belon, C.; Galtier-Dereure, F.; Bringer, J.; Lesimple, T.; Namer, M.; Cutuli, B. F.; Pujol, H.; Sultan, C. Androgen receptor gene mutation in male breast cancer. Hum. Mol. Genet., 1993, 2(11), 1799-1802.
114. Zhang, Y. H.; Guo, W.; Wagner, R. L.; Huang, B. L.; McCabe, L.; Vilain, E.; Burris, T. P.; Anyane-Yeboa, K.; Burghes, A. H.; Chitayat, D.; Chudley, A. E.; Genel, M.; Gertner, J. M.; Klingensmith, G. J.; Levine, S. N.; Nakamoto, J.; New, M. I.; Pagon, R. A.; Pappas, J. G.; Quigley, C. A.; Rosenthal, I. M.; Baxter, J. D.; Fletterick, R. J.; McCabe, E. R. DAX1 mutations map to putative structural domains in a deduced three-dimensional model. Am. J. Hum. Genet., 1998, 62(4), 855-864.
115. Lundberg Giwercman, Y.; Nikoshkov, A.; Lindsten, K.; Bystrom, B.; Pousette, A.; Chibalin, A. V.; Arvidsson, S.; Tiulpakov, A.; Semitcheva, T. V.; Peterkova, V.; Hagenfeldt, K.; Ritzen, E. M.; Wedell, A. Functional characterisation of mutations in the ligand-binding domain of the androgen receptor gene in patients with androgen insensitivity syndrome. Hum. Genet., 1998, 103(4), 529-531.
116. Hiort, O.; Wodtke, A.; Struve, D.; Zollner, A.; Sinnecker, G. H. Detection of point mutations in the androgen receptor gene using non-isotopic single strand conformation polymorphism analysis. German Collaborative Intersex Study Group. Hum. Mol. Genet., 1994, 3(7), 1163-1166.
117. Shkolny, D. L.; Beitel, L. K.; Ginsberg, J.; Pekeles, G.; Arbour, L.; Pinsky, L.; Trifiro, M. A. Discordant measures of androgen-binding kinetics in two mutant androgen receptors causing mild or partial androgen insensitivity, respectively. J. Clin. Endocrinol. Metab., 1999, 84(2), 805-810.
118. Tincello, D. G.; Saunders, P. T.; Hodgins, M. B.; Simpson, N. B.; Edwards, C. R.; Hargreaves, T. B.; Wu, F. C. Correlation of clinical, endocrine and molecular abnormalities with in vivo responses to high-dose testosterone in patients with partial androgen insensitivity syndrome. Clin. Endocrinol. (Oxf), 1997, 46(4), 497-506.
119. Knoke, I.; Jakubiczka, S.; Lehnert, H.; Wieacker, P. A new point mutation of the androgen receptor gene in a patient with partial androgen resistance and severe oligozoospermia. Andrologia., 1999, 31(4), 199-201.
120. Nakao, R.; Haji, M.; Yanase, T.; Ogo, A.; Takayanagi, R.; Katsube, T.; Fukumaki, Y.; Nawata, H. A single amino acid substitution (Met786Val) in the steroid-binding domain of human androgen receptor leads to complete androgen insensitivity syndrome. J. Clin. Endocrinol. Metab., 1992, 74(5), 1152-1157.
121. Deeb, A.; Mason, C.; Lee, Y. S.; Hughes, I. A. Correlation between genotype, phenotype and sex of rearing in 111 patients with partial androgen insensitivity syndrome. Clin. Endocrinol. (Oxf), 2005, 63(1), 56-62.
122. Tsukada, T.; Inoue, M.; Tachibana, S.; Nakai, Y.; Takebe, H. An androgen receptor mutation causing androgen resistance in undervirilized male syndrome. J. Clin. Endocrinol. Metab., 1994, 79(4), 1202-1207.
123. Jakubiczka, S.; Nedel, S.; Werder, E. A.; Schleiermacher, E.; Theile, U.; Wolff, G.; Wieacker, P. Mutations of the androgen receptor gene in patients with complete androgen insensitivity. Hum. Mutat., 1997, 9(1), 57-61.
124. Brown, T. R.; Scherer, P. A.; Chang, Y. T.; Migeon, C. J.; Ghirri, P.; Murono, K.; Zhou, Z. Molecular genetics of human androgen insensitivity. Eur. J. Pediatr., 1993, 152 (Suppl 2), S62-69.
125. Adeyemo, O.; Kallio, P. J.; Palvimo, J. J.; Kontula, K.; Janne, O. A. A single-base substitution in exon 6 of the androgen receptor gene causing complete androgen insensitivity: the mutated receptor fails to transactivate but binds to DNA in vitro. Hum. Mol. Genet., 1993, 2(11), 1809-1812.
126. Ong, Y. C.; Kolatkar, P. R.; Yong, E. L. Androgen receptor mutations causing human androgen insensitivity syndromes show a key role of residue M807 in Helix 8-Helix 10 interactions and in receptor ligand-binding domain stability. Mol. Hum. Reprod., 2002, 8(2), 101-108.
127. Ong, Y. C.; Wong, H. B.; Adaikan, G.; Yong, E. L. Directed pharmacological therapy of ambiguous genitalia due to an androgen receptor gene mutation. Lancet, 1999, 354(9188), 1444-1445.
128. Yaegashi, N.; Uehara, S.; Senoo, M.; Sato, J.; Fujiwara, J.; Funato, T.; Sasaki, T.; Yajima, A. Point mutations in the steroid-binding domain of the androgen receptor gene of five Japanese patients with androgen insensitivity syndrome. Tohoku. J. Exp. Med., 1999, 187(3), 263-272.
129. Shkolny, D. L.; Brown, T. R.; Punnett, H. H.; Kaufman, M.; Trifiro, M. A.; Pinsky, L. Characterization of alternative amino acid substitutions at arginine 830 of the androgen receptor that cause complete androgen insensitivity in three families. Hum. Mol. Genet., 1995, 4(4), 515-521.
130. Chen, C. P.; Chern, S. R.; Chen, B. F.; Wang, W.; Hwu, Y. M. Hamartoma in a pubertal patient with complete androgen insensitivity syndrome and R183X mutation of the androgen receptor gene. Fertil. Steril., 2000, 74(1), 182-183.
131. Georget, V.; Terouanne, B.; Lumbroso, S.; Nicolas, J. C.; Sultan, C. Trafficking of androgen receptor mutants fused to green fluorescent protein: a new investigation of partial androgen insensitivity syndrome. J. Clin. Endocrinol. Metab., 1998, 83(10), 3597-3603.
132. Melo, K. F.; Latronico, A. C.; Costa, E. M.; Billerbeck, A. E.; Mendonca, B. B.; Arnhold, I. J. A novel point mutation (R840S) in the androgen receptor in a Brazilian family with partial androgen insensitivity syndrome. Hum. Mutat., 1999, 14(4), 353.
133. Melo, K. F.; Mendonca, B. B.; Billerbeck, A. E.; Costa, E. M.; Inacio, M.; Silva, F. A.; Leal, A. M.; Latronico, A. C.; Arnhold, I. J. Clinical, hormonal, behavioral, and genetic characteristics of androgen insensitivity syndrome in a Brazilian cohort: five novel mutations in the androgen receptor gene. J. Clin. Endocrinol. Metab., 2003, 88(7), 3241-3250.
134. Mongan, N. P.; Jaaskelainen, J.; Green, K.; Schwabe, J. W.; Shimura, N.; Dattani, M.; Hughes, I. A. Two de novo mutations in the AR gene cause the complete androgen insensitivity syndrome in a pair of monozygotic twins. J. Clin. Endocrinol. Metab., 2002, 87(3), 1057-1061.
135. De Bellis, A.; Quigley, C. A.; Marschke, K. B.; el-Awady, M. K.; Lane, M. V.; Smith, E. P.; Sar, M.; Wilson, E. M.; French, F. S. Characterization of mutant androgen receptors causing partial androgen insensitivity syndrome. J. Clin. Endocrinol. Metab., 1994, 78(3), 513-522.
136. Hiort, O.; Huang, Q.; Sinnecker, G. H.; Sadeghi-Nejad, A.; Kruse, K.; Wolfe, H. J.; Yandell, D. W. Single strand conformation polymorphism analysis of androgen receptor gene mutations in patients with androgen insensitivity syndromes: application for diagnosis, genetic counseling, and therapy. J. Clin. Endocrinol. Metab., 1993, 77(1), 262-266.
137. Taplin, M. E.; Bubley, G. J.; Ko, Y. J.; Small, E. J.; Upton, M.; Rajeshkumar, B.; Balk, S. P. Selection for androgen receptor mutations in prostate cancers treated with androgen antagonist. Cancer Res., 1999, 59(11), 2511-2515.
138. Davies, H. R.; Hughes, I. A.; Patterson, M. N. Genetic counselling in complete androgen insensitivity syndrome: trinucleotide repeat polymorphisms, single-strand conformation polymorphism and direct detection of two novel mutations in the androgen receptor gene. Clin. Endocrinol. (Oxf), 1995, 43(1), 69-77.
139. Song, L. N.; Herrell, R.; Byers, S.; Shah, S.; Wilson, E. M.; Gelmann, E. P. β-Catenin binds to the activation function 2 region of the androgen receptor and modulates the effects of the N-terminal domain and TIF2 on ligand-dependent transcription. Mol. Cell. Biol., 2003, 23(5), 1674-1687.
140. Thompson, J.; Saatcioglu, F.; Janne, O. A.; Palvimo, J. J. Disrupted amino- and carboxyl-terminal interactions of the androgen receptor are linked to androgen insensitivity. Mol. Endocrinol., 2001, 15(6), 923-935.
141. Watanabe, M.; Ushijima, T.; Shiraishi, T.; Yatani, R.; Shimazaki, J.; Kotake, T.; Sugimura, T.; Nagao, M. Genetic alterations of androgen receptor gene in Japanese human prostate cancer. Jpn. J. Clin. Oncol., 1997, 27(6), 389-393.
142. McInerney, E. M.; Ince, B. A.; Shapiro, D. J.; Katzenellenbogen, B. S. A transcriptionally active estrogen receptor mutant is a novel type of dominant negative inhibitor of estrogen action. Mol. Endocrinol., 1996, 10(12), 1519-1526.
143. Furuta, H.; Iwasaki, N.; Oda, N.; Hinokio, Y.; Horikawa, Y.; Yamagata, K.; Yano, N.; Sugahiro, J.; Ogata, M.; Ohgawara, H.; Omori, Y.; Iwamoto, Y.; Bell, G. I. Organization and partial sequence of the hepatocyte nuclear factor-4α/MODY1 gene and identification of a missense mutation, R127W, in a Japanese family with MODY. Diabetes, 1997, 46(10), 1652-1657.
144. Fajans, S. S.; Bell, G. I.; Polonsky, K. S. Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. N. Engl. J. Med., 2001, 345(13), 971-980.
145. Moller, A. M.; Urhammer, S. A.; Dalgaard, L. T.; Reneland, R.; Berglund, L.; Hansen, T.; Clausen, J. O.; Lithell, H.; Pedersen, O. Studies of the genetic variability of the coding region of the hepatocyte nuclear factor-4α in Caucasians with maturity onset NIDDM. Diabetologia, 1997, 40(8), 980-983.
146. Bulman, M. P.; Dronsfield, M. J.; Frayling, T.; Appleton, M.; Bain, S. C.; Ellard, S.; Hattersley, A. T. A missense mutation in the hepatocyte nuclear factor 4α gene in a UK pedigree with maturity-onset diabetes of the young. Diabetologia., 1997, 40(7), 859-862.
147. Muscatelli, F.; Strom, T. M.; Walker, A. P.; Zanaria, E.; Recan, D.; Meindl, A.; Bardoni, B.; Guioli, S.; Zehetner, G.; Rabl, W.; et al. Mutations in the DAX-1 gene give rise to both X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism. Nature, 1994, 372(6507), 672-676.
148. Nakae, J.; Abe, S.; Tajima, T.; Shinohara, N.; Murashita, M.; Igarashi, Y.; Kusuda, S.; Suzuki, J.; Fujieda, K. Three novel mutations and a de novo deletion mutation of the DAX-1 gene in patients with X-linked adrenal hypoplasia congenita. J. Clin. Endocrinol. Metab., 1997, 82(11), 3835-3841.
149. Ozisik, G.; Mantovani, G.; Achermann, J. C.; Persani, L.; Spada, A.; Weiss, J.; Beck-Peccoz, P.; Jameson, J. L. An alternate translation initiation site circumvents an amino-terminal DAX1 nonsense mutation leading to a mild form of X-linked adrenal hypoplasia congenita. J. Clin. Endocrinol. Metab., 2003, 88(1), 417-423.
150. Achermann, J. C.; Ito, M.; Silverman, B. L.; Habiby, R. L.; Pang, S.; Rosler, A.; Jameson, J. L. Missense mutations cluster within the carboxyl-terminal region of DAX-1 and impair transcriptional repression. J. Clin. Endocrinol. Metab., 2001, 86(7), 3171-3175.
151. Takahashi, T.; Shoji, Y.; Shoji, Y.; Haraguchi, N.; Takahashi, I.; Takada, G. Active hypothalamic-pituitary-gonadal axis in an infant with X-linked adrenal hypoplasia congenita. J. Pediatr., 1997, 130(3), 485-488.
152. Mantovani, G.; Ozisik, G.; Achermann, J. C.; Romoli, R.; Borretta, G.; Persani, L.; Spada, A.; Jameson, J. L.; Beck-Peccoz, P. Hypogonadotropic hypogonadism as a presenting feature of late-onset X-linked adrenal hypoplasia congenita. J. Clin. Endocrinol. Metab., 2002, 87(1), 44-48.
153. Achermann, J. C.; Silverman, B. L.; Habiby, R. L.; Jameson, J. L. Presymptomatic diagnosis of X-linked adrenal hypoplasia congenita by analysis of DAX1. J. Pediatr., 2000, 137(6), 878-881.
154. Tabarin, A.; Achermann, J. C.; Recan, D.; Bex, V.; Bertagna, X.; Christin-Maitre, S.; Ito, M.; Jameson, J. L.; Bouchard, P. A novel mutation in DAX1 causes delayed-onset adrenal insufficiency and incomplete hypogonadotropic hypogonadism. J. Clin. Invest., 2000, 105(3), 321-328.
155. Schwartz, M.; Blichfeldt, S.; Muller, J. X-linked adrenal hypoplasia in a large Greenlandic family. Detection of a missense mutation (N4401) in the DAX-1 gene; implication for genetic counselling and carrier diagnosis. Hum. Genet., 1997, 99(1), 83-87.
156. Lalli, E.; Ohe, K.; Hindelang, C.; Sassone-Corsi, P. Orphan receptor DAX-1 is a shuttling RNA binding protein associated with polyribosomes via mRNA. Mol. Cell. Biol., 2000, 20(13), 4910-4921.
157. Nishigori, H.; Tomura, H.; Tonooka, N.; Kanamori, M.; Yamada, S.; Sho, K.; Inoue, I.; Kikuchi, N.; Onigata, K.; Kojima, I.; Kohama, T.; Yamagata, K.; Yang, Q.; Matsuzawa, Y.; Miki, T.; Seino, S.; Kim, M. Y.; Choi, H. S.; Lee, Y. K.; Moore, D. D.; Takeda, J. Mutations in the small heterodimer partner gene are associated with mild obesity in Japanese subjects. Proc. Natl. Acad. Sci. USA, 2001, 98(2), 575-580.
158. Milam, A. H.; Rose, L.; Cideciyan, A. V.; Barakat, M. R.; Tang, W. X.; Gupta, N.; Aleman, T. S.; Wright, A. F.; Stone, E. M.; Sheffield, V. C.; Jacobson, S. G. The nuclear receptor NR2E3 plays a role in human retinal photoreceptor differentiation and degeneration. Proc. Natl. Acad. Sci. USA, 2002, 99(1), 473-478.
159. Haider, N. B.; Jacobson, S. G.; Cideciyan, A. V.; Swiderski, R.; Streb, L. M.; Searby, C.; Beck, G.; Hockey, R.; Hanna, D. B.; Gorman, S.; Duhl, D.; Carmi, R.; Bennett, J.; Weleber, R. G.; Fishman, G. A.; Wright, A. F.; Stone, E. M.; Sheffield, V. C. Mutation of a nuclear receptor gene, NR2E3, causes enhanced S cone syndrome, a disorder of retinal cell fate. Nat. Genet., 2000, 24(2), 127-131.
160. Huizenga, N. A.; Koper, J. W.; De Lange, P.; Pols, H. A.; Stolk, R. P.; Burger, H.; Grobbee, D. E.; Brinkmann, A. O.; De Jong, F. H.; Lamberts, S. W. A polymorphism in the glucocorticoid receptor gene may be associated with and increased sensitivity to glucocorticoids in vivo. J. Clin. Endocrinol. Metab., 1998, 83(1), 144-151.
161. Powers, J. H.; Hillmann, A. G.; Tang, D. C.; Harmon, J. M. Cloning and expression of mutant glucocorticoid receptors from glucocorticoid-sensitive and -resistant human leukemic cells. Cancer Res., 1993, 53(17), 4059-4065.
162. Kino, T.; Stauber, R. H.; Resau, J. H.; Pavlakis, G. N.; Chrousos, G. P. Pathologic human GR mutant has a transdominant negative effect on the wild-type GR by inhibiting its translocation into the nucleus: importance of the ligand-binding domain for intracellular GR trafficking. J. Clin. Endocrinol. Metab., 2001, 86(11), 5600-5608.
163. Mendonca, B. B.; Leite, M. V.; de Castro, M.; Kino, T.; Elias, L. L.; Bachega, T. A.; Arnhold, I. J.; Chrousos, G. P.; Latronico, A. C. Female pseudohermaphroditism caused by a novel homozygous missense mutation of the GR gene. J. Clin. Endocrinol. Metab., 2002, 87(4), 1805-1809.
164. Hurley, D. M.; Accili, D.; Stratakis, C. A.; Karl, M.; Vamvakopoulos, N.; Rorer, E.; Constantine, K.; Taylor, S. I.; Chrousos, G. P. Point mutation causing a single amino acid substitution in the hormone binding domain of the glucocorticoid receptor in familial glucocorticoid resistance. J. Clin. Invest., 1991, 87(2), 680-686.
165. Malchoff, D. M.; Brufsky, A.; Reardon, G.; McDermott, P.; Javier, E. C.; Bergh, C. H.; Rowe, D.; Malchoff, C. D. A mutation of the glucocorticoid receptor in primary cortisol resistance. J. Clin. Invest., 1993, 91(5), 1918-1925.
166. Vottero, A.; Kino, T.; Combe, H.; Lecomte, P.; Chrousos, G. P. A novel, C-terminal dominant negative mutation of the GR causes familial glucocorticoid resistance through abnormal interactions with p160 steroid receptor coactivators. J. Clin. Endocrinol. Metab., 2002, 87(6), 2658-2667.
167. Ashraf, J.; Thompson, E. B. Identification of the activation-labile gene: a single point mutation in the human glucocorticoid receptor presents as two distinct receptor phenotypes. Mol. Endocrinol., 1993, 7(5), 631-642.
168. Zennaro, M. C.; Souque, A.; Viengchareun, S.; Poisson, E.; Lombes, M. A new human MR splice variant is a ligand-independent transactivator modulating corticosteroid action. Mol. Endocrinol., 2001, 15(9), 1586-1598.
169. Arai, K.; Nakagomi, Y.; Iketani, M.; Shimura, Y.; Amemiya, S.; Ohyama, K.; Shibasaki, T. Functional polymorphisms in the mineralocorticoid receptor and amirolide-sensitive sodium channel genes in a patient with sporadic pseudohypoaldosteronism. Hum. Genet., 2003, 112(1), 91-97.
170. Geller, D. S.; Farhi, A.; Pinkerton, N.; Fradley, M.; Moritz, M.; Spitzer, A.; Meinke, G.; Tsai, F. T.; Sigler, P. B.; Lifton, R. P. Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy. Science, 2000, 289(5476), 119-123.
171. Tajima, T.; Kitagawa, H.; Yokoya, S.; Tachibana, K.; Adachi, M.; Nakae, J.; Suwa, S.; Katoh, S.; Fujieda, K. A novel missense mutation of mineralocorticoid receptor gene in one Japanese family with a renal form of pseudohypoaldosteronism type 1. J. Clin. Endocrinol. Metab., 2000, 85(12), 4690-4694.
172. Achermann, J. C.; Ito, M.; Ito, M.; Hindmarsh, P. C.; Jameson, J. L. A mutation in the gene encoding steroidogenic factor-1 causes XY sex reversal and adrenal failure in humans. Nat. Genet., 1999, 22(2), 125-126.
173. Achermann, J. C.; Ozisik, G.; Ito, M.; Orun, U. A.; Harmanci, K.; Gurakan, B.; Jameson, J. L. Gonadal determination and adrenal development are regulated by the orphan nuclear receptor steroidogenic factor-1, in a dose-dependent manner. J. Clin. Endocrinol. Metab., 2002, 87(4), 1829-1833.
174. Vohl, M. C.; Lepage, P.; Gaudet, D.; Brewer, C. G.; Betard, C.; Perron, P.; Houde, G.; Cellier, C.; Faith, J. M.; Despres, J. P.; Morgan, K.; Hudson, T. J. Molecular scanning of the human PPAR α gene: association of the L162V mutation with hyperapobetalipoproteinemia. J. Lipid. Res., 2000, 41(6), 945-952.
175. Ristow, M.; Muller-Wieland, D.; Pfeiffer, A.; Krone, W.; Kahn, C. R. Obesity associated with a mutation in a genetic regulator of adipocyte differentiation. N. Engl. J. Med., 1998, 339(14), 953-959.
176. Hansen, L.; Ekstrom, C. T.; Tabanera, Y. P. R.; Anant, M.; Wassermann, K.; Reinhardt, R. R. The Pro12Ala variant of the PPARG gene is a risk factor for peroxisome proliferator-activated receptor-γ/α agonist-induced edema in type 2 diabetic patients. J. Clin. Endocrinol. Metab., 2006, 91(9), 3446-3450.
177. Barroso, I.; Gurnell, M.; Crowley, V. E.; Agostini, M.; Schwabe, J. W.; Soos, M. A.; Maslen, G. L.; Williams, T. D.; Lewis, H.; Schafer, A. J.; Chatterjee, V. K.; O'Rahilly, S. Dominant negative mutations in human PPARγ associated with severe insulin resistance, diabetes mellitus and hypertension. Nature, 1999, 402(6764), 880-883.
178. Hegele, R. A.; Cao, H.; Frankowski, C.; Mathews, S. T.; Leff, T. PPARG F388L, a transactivation-deficient mutant, in familial partial lipodystrophy. Diabetes, 2002, 51(12), 3586-3590.
179. Agarwal, A. K.; Garg, A. A novel heterozygous mutation in peroxisome proliferator-activated receptor-γ gene in a patient with familial partial lipodystrophy. J. Clin. Endocrinol. Metab., 2002, 87(1), 408-411.
180. Behr, M.; Loos, U. A point mutation (Ala229 to Thr) in the hinge domain of the c-erbAβ thyroid hormone receptor gene in a family with generalized thyroid hormone resistance. Mol. Endocrinol., 1992, 6(7), 1119-1126.
181. Pohlenz, J.; Schonberger, W.; Wemme, H.; Winterpacht, A.; Wirth, S.; Zabel, B. New point mutation (R243W) in the hormone binding domain of the C-erbA β1 gene in a family with generalized resistance to thyroid hormone. Hum. Mutat., 1996, 7(1), 79-81.
182. Geffner, M. E.; Su, F.; Ross, N. S.; Hershman, J. M.; Van Dop, C.; Menke, J. B.; Hao, E.; Stanzak, R. K.; Eaton, T.; Samuels, H. H.; et al. An arginine to histidine mutation in codon 311 of the C-erbAβ gene results in a mutant thyroid hormone receptor that does not mediate a dominant negative phenotype. J. Clin. Invest., 1993, 91(2), 538-546.
183. Parrilla, R.; Mixson, A. J.; McPherson, J. A.; McClaskey, J. H.; Weintraub, B. D. Characterization of seven novel mutations of the c-erbAβ gene in unrelated kindreds with generalized thyroid hormone resistance. Evidence for two "hot spot" regions of the ligand binding domain. J. Clin. Invest., 1991, 88(6), 2123-2130.
184. Weiss, R. E.; Weinberg, M.; Refetoff, S. Identical mutations in unrelated families with generalized resistance to thyroid hormone occur in cytosine-guanine-rich areas of the thyroid hormone receptor β gene. Analysis of 15 families. J. Clin. Invest., 1993, 91(6), 2408-2415.
185. Cugini, C. D., Jr.; Leidy, J. W., Jr.; Chertow, B. S.; Berard, J.; Bradley, W. E.; Menke, J. B.; Hao, E. H.; Usala, S. J. An arginine to histidine mutation in codon 315 of the c-erbAβ thyroid hormone receptor in a kindred with generalized resistance to thyroid hormones results in a receptor with significant 3,5,3′-triiodothyronine binding activity. J. Clin. Endocrinol. Metab., 1992, 74(5), 1164-1170.
186. Usala, S. J.; Menke, J. B.; Watson, T. L.; Berard, W. E.; Bradley, C.; Bale, A. E.; Lash, R. W.; Weintraub, B. D. A new point mutation in the 3,5,3′-triiodothyronine-binding domain of the c-erbAβ thyroid hormone receptor is tightly linked to generalized thyroid hormone resistance. J. Clin. Endocrinol. Metab., 1991, 72(1), 32-38.
187. Seto, D.; Weintraub, B. D. Rapid molecular diagnosis of mutations associated with generalized thyroid hormone resistance by PCR-coupled automated direct sequencing of genomic DNA: detection of two novel mutations. Hum. Mutat., 1996, 8(3), 247-257.
188. Sakurai, A.; Takeda, K.; Ain, K.; Ceccarelli, P.; Nakai, A.; Seino, S.; Bell, G. I.; Refetoff, S.; DeGroot, L. J. Generalized resistance to thyroid hormone associated with a mutation in the ligand-binding domain of the human thyroid hormone receptor beta. Proc. Natl. Acad. Sci. USA, 1989, 86(22), 8977-8981.
189. Adams, M.; Nagaya, T.; Tone, Y.; Jameson, J. L.; Chatterjee, V. K. Functional properties of a novel mutant thyroid hormone receptor in a family with generalized thyroid hormone resistance syndrome. Clin. Endocrinol. (Oxf), 1992, 36(3), 281-289.
190. 3 receptor β1 gene in a kindred of generalized resistance to thyroid hormone. Mol. Cell Endocrinol., 1992, 84(3), 159-166.
191. Weiss, R. E.; Chyna, B.; Duell, P. B.; Hayashi, Y.; Sunthornthepvarakul, T.; Refetoff, S. A new point mutation (C446R) in the thyroid hormone receptor-β gene of a family with resistance to thyroid hormone. J. Clin. Endocrinol. Metab., 1994, 78(5), 1253-1256.
192. Usala, S. J.; Tennyson, G. E.; Bale, A. E.; Lash, R. W.; Gesundheit, N.; Wondisford, F. E.; Accili, D.; Hauser, P.; Weintraub, B. D. A base mutation of the C-erbAβ thyroid hormone receptor in a kindred with generalized thyroid hormone resistance. Molecular heterogeneity in two other kindreds. J. Clin. Invest., 1990, 85(1), 93-100.
193. Refetoff, S.; Weiss, R. E.; Wing, J. R.; Sarne, D.; Chyna, B.; Hayashi, Y. Resistance to thyroid hormone in subjects from two unrelated families is associated with a point mutation in the thyroid hormone receptor-β gene resulting in the replacement of the normal proline 453 with serine. Thyroid, 1994, 4(3), 249-254.
194. Hughes, M. R.; Malloy, P. J.; Kieback, D. G.; Kesterson, R. A.; Pike, J. W.; Feldman, D.; O'Malley, B. W. Point mutations in the human vitamin D receptor gene associated with hypocalcemic rickets. Science, 1988, 242(4886), 1702-1705.
195. Yagi, H.; Ozono, K.; Miyake, H.; Nagashima, K.; Kuroume, T.; Pike, J. W. A new point mutation in the deoxyribonucleic acid-binding domain of the vitamin D receptor in a kindred with hereditary 1,25-dihydroxyvitamin D-resistant rickets. J. Clin. Endocrinol. Metab., 1993, 76(2), 509-512.
196. Rut, A. R.; Hewison, M.; Kristjansson, K.; Luisi, B.; Hughes, M. R.; O'Riordan, J. L. Two mutations causing vitamin D resistant rickets: modelling on the basis of steroid hormone receptor DNA-binding domain crystal structures. Clin. Endocrinol. (Oxf), 1994, 41(5), 581-590.
197. Lin, N. U.; Malloy, P. J.; Sakati, N.; al-Ashwal, A.; Feldman, D. A novel mutation in the deoxyribonucleic acid-binding domain of the vitamin D receptor causes hereditary 1,25-dihydroxyvitamin Dresistant rickets. J. Clin. Endocrinol. Metab., 1996, 81(7), 2564-2569.
198. Saijo, T.; Ito, M.; Takeda, E.; Huq, A. H.; Naito, E.; Yokota, I.; Sone, T.; Pike, J. W.; Kuroda, Y. A unique mutation in the vitamin D receptor gene in three Japanese patients with vitamin D-dependent rickets type II: utility of single-strand conformation polymorphism analysis for heterozygous carrier detection. Am. J. Hum. Genet., 1991, 49(3), 668-673.
199. Malloy, P. J.; Weisman, Y.; Feldman, D. Hereditary 1α,25- dihydroxyvitamin D-resistant rickets resulting from a mutation in the vitamin D receptor deoxyribonucleic acid-binding domain. J. Clin. Endocrinol. Metab., 1994, 78(2), 313-316.
200. 3. Mol. Endocrinol., 1990, 4(4), 623-631.
201. Kristjansson, K.; Rut, A. R.; Hewison, M.; O'Riordan, J. L.; Hughes, M. R. Two mutations in the hormone binding domain of the vitamin D receptor cause tissue resistance to 1,25 dihydroxyvitamin D3. J. Clin. Invest., 1993, 92(1), 12-16.
202. Malloy, P. J.; Eccleshall, T. R.; Gross, C.; Van Maldergem, L.; Bouillon, R.; Feldman, D. Hereditary vitamin D resistant rickets caused by a novel mutation in the vitamin D receptor that results in decreased affinity for hormone and cellular hyporesponsiveness. J. Clin. Invest., 1997, 99(2), 297-304.
203. 3: point mutations confer reduced transactivation in response to ligand and impaired interaction with the retinoid X receptor heterodimeric partner. Mol. Endocrinol., 1996, 10(12), 1617-1631.